Baylor Scott and White Health

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Idiopathic pulmonary fibrosis1 trial
• Prostate cancer1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Janssen Research & Development, LLC1 trial
• Laekna Limited1 trial
• Rein Therapeutics1 trial

Running trials

• Recruiting

  A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  NCT06968845· Phase 2· Rein Therapeutics· Source

  Contact: Vanessa George

• Recruiting

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting

Closed trials

• Terminated

  A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

  NCT05780736· Bristol-Myers Squibb· Source

• Completed

  Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib Patients With m-CRPC

  NCT04060394· Phase 1/2· Laekna Limited· Source